Marsh, staying ahead of issues impacting clients, is hosting a conference on the risk and insurance implications arising from stricter compliance and regulatory requirements for clinical trials conducted in Europe. The Marsh 2010 Clinical Trials Conference will take place in London on 13-14 October at the Waldorf Hilton Hotel, Aldwych, London.

Among the major issues to be discussed at the conference are:

• The future of clinical trials in the European Union, following the public consultation on changes to the Clinical Trials Directive
• How companies should address and effectively manage their responsibilities, and the potential liabilities, that exist as part of a clinical trial
• Insurers’ concerns surrounding clinical trials and how these influence the solutions they provide
• How clinical trial operators can ensure compliance with specific geographical insurance requirements
• Building a successful litigation strategy and how to defend your organization – and its reputation – against adverse events or claims

Christopher Bryce, European Chemical and Life Science Practice Leader at Marsh, commented: "Clinical trials are expanding globally at a rapid pace, particularly in emerging territories such as Brazil and India. At the same time, organizations face numerous challenges stemming from complex regulation and country-specific legislation. Good risk management enables compliance with these requirements and helps create success. The chemical and life science industry needs to stay informed of the latest risk, legislative and regulatory developments if it wishes to remain successful in the future.”

Those wishing to attend the conference can register here.

NOTE: Journalists are welcome to attend the conference and should RSVP either to Eileen Mercer or Jason Groves.